Trial · NCT03155997
Adverse events848
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
161 to 180 of 848
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Joint stiffness | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 22 | 2,791 | 25 |
| other | Joint stiffness | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 56 | 2,800 | 59 |
| other | Muscle spasms | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 134 | 2,791 | 180 |
| other | Muscle spasms | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 100 | 2,800 | 121 |
| other | Muscular weakness | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 29 | 2,791 | 31 |
| other | Muscular weakness | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 16 | 2,800 | 16 |
| other | Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 70 | 2,791 | 77 |
| other | Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 72 | 2,800 | 76 |
| other | Musculoskeletal pain | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 111 | 2,791 | 120 |
| other | Musculoskeletal pain | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 154 | 2,800 | 170 |
| other | Musculoskeletal stiffness | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 32 | 2,791 | 34 |
| other | Musculoskeletal stiffness | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 33 | 2,800 | 37 |
| other | Myalgia | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 167 | 2,791 | 193 |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 163 | 2,800 | 185 |
| other | Neck pain | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 48 | 2,791 | 49 |
| other | Neck pain | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 59 | 2,800 | 64 |
| other | Osteopenia | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 30 | 2,791 | 30 |
| other | Osteopenia | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 32 | 2,800 | 32 |
| other | Osteoporosis | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 45 | 2,791 | 45 |
| other | Osteoporosis | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 71 | 2,800 | 75 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03155997/events?page=9